21
The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

  • Upload
    vera

  • View
    40

  • Download
    1

Embed Size (px)

DESCRIPTION

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome. Thank you for taking the pre-assessment. These questions will be repeated at the end of the activity. CHAMPION Trials: Study Designs. CHAMPION Trials Primary End Point and Stent Thrombosis. - PowerPoint PPT Presentation

Citation preview

Page 1: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

The Role of Intravenous and Oral Antiplatelet Agents in Acute

Coronary Syndrome

Page 2: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Thank you for taking the pre-assessment.

These questions will be repeated at the end of the activity.

Page 3: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

CHAMPION Trials: Study Designs

Page 4: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

CHAMPION Trials Primary End Point and Stent Thrombosis

Page 5: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Antiplatelet Therapy in ACS

Page 6: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

ADP Receptor Antagonists in ACS

Page 7: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 8: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

2013 ACCF/AHA Guideline for STEMI

Page 9: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 10: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 11: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

ARCTIC No Advantage With Platelet Function- Guided

Therapy

Page 12: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Glycoprotein IIb/IIIa vs Cangrelor

Page 13: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION TrialsDeath, MI, IDR, Stent Thrombosis

Page 14: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION Trials (cont)Death, MI, IDR, Stent Thrombosis in Subgroups

Page 15: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 16: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION TrialsNon-CABG Bleeding at 48 h, Safety

Page 17: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Abbreviations

Page 18: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Abbreviations (cont)

Page 19: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References

Page 20: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References (cont)

Page 21: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References (cont)